Medicare Still Silent on Obesity Drug Costs as of June 1, 2026

Medicare has yet to release information regarding the potential costs of providing seniors with obesity drugs priced at $50. This inquiry has been ongoing for several weeks.

As of June 1, 2026, details concerning the financial implications of including these medications in Medicare’s coverage plan remain undisclosed. The continued lack of information from Medicare leaves questions unanswered about the budgetary impact of such a program.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 1, 2026

Author

GOAI